Axonics Modulation Technologies

YTD

ALL

Why Robinhood?

You can watch AXNX and buy or sell other stocks, ETFs, and their options commission-free!

About AXNX

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women.

CEO

Raymond Wayne Cohen

CEORaymond Wayne Cohen

Employees

—

Employees—

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

2012

Founded2012

Employees

—

Employees—

AXNX Key Statistics

Market cap

3.63B

Market cap3.63B

Price-Earnings ratio

-657.22

Price-Earnings ratio-657.22

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$71.05

52 Week high$71.05

52 Week low

$55.09

52 Week low$55.09

People also own

Based on the portfolios of people who own AXNX. This list is generated using Robinhood data, and it’s not a recommendation.